Literature DB >> 2860429

HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.

P Kühnl, S Seidl, G Holzberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860429     DOI: 10.1016/s0140-6736(85)92910-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus.

Authors:  P Portincasa; G Conti; M Gerloni; C Chezzi
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

2.  Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence.

Authors:  R S Blumberg; E G Sandstrom; T J Paradis; D N Neumeyer; M G Sarngadharan; K L Hartshorn; R E Byington; M S Hirsch; R T Schooley
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

3.  Concomitant infection of HTLV-I and HIV-1: prevalence of IgG and IgM antibodies in Washington, D.C. area.

Authors:  K S Chang; L C Wang; C L Gao; S Alexander; R C Ting; A Bodner; T Log; A F Kuo; P Strickland
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

4.  Markers of HTLV-III in patients with end stage renal failure.

Authors:  R S Rodger; J S Tapson; A A Codd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

5.  AIDS virus antibody in polytransfused dialysis patients vaccinated against hepatitis B.

Authors:  J Desmyter; M Reynders; P Goubau
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

6.  Synthetic-peptide-based enzyme-linked immunosorbent assay for screening human serum or plasma for antibodies to human immunodeficiency virus type 1 and type 2.

Authors:  L Gonzalez; R W Boyle; M Zhang; J Castillo; S Whittier; P Della-Latta; L M Clarke; J R George; X Fang; J G Wang; B Hosein; C Y Wang
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

7.  Anti-HIV seroprevalence in California blood and plasma donors.

Authors:  C I Perkins; K W Kizer; M J Hughes; P V Holland; J C Lloyd
Journal:  West J Med       Date:  1988-11

8.  Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III.

Authors:  L E Henderson; R Sowder; T D Copeland; S Oroszlan; L O Arthur; W G Robey; P J Fischinger
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

9.  Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology.

Authors:  B Forghani; J W Hurst; C S Chan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

10.  Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies.

Authors:  J R Carlson; J Yee; S H Hinrichs; M L Bryant; M B Gardner; N C Pedersen
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.